Загрузка...
Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
Rivaroxaban is a new oral anticoagulant used for the prevention of stroke in patients with atrial fibrillation. Hemorrhagic pericarditis is known to occur with rivaroxaban; however, only a few case reports in the literature describe such events. Recently, we experienced hemorrhagic pericarditis that...
Сохранить в:
| Опубликовано в: : | Transl Clin Pharmacol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society for Clinical Pharmacology and Therapeutics
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033380/ https://ncbi.nlm.nih.gov/pubmed/32095464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2017.25.3.138 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|